The report provides a detailed analysis essential for establishing a Metaxalone production plant. It encompasses all critical aspects necessary for Metaxalone production, including the cost of Metaxalone production, Metaxalone plant cost, Metaxalone production costs, and the overall Metaxalone production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Metaxalone production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Metaxalone is a centrally acting skeletal muscle relaxant that is used to relieve muscle pain, stiffness, and discomfort caused by strains, sprains, and other musculoskeletal conditions. It works by depressing nerve activity in the brain and spinal cord, which helps relax muscles without directly acting on muscle tissue. It is used as an adjunct to rest, physical therapy, and other measures for short-term relief of acute painful muscle spasms and related conditions. It improves movement and decreases muscle rigidity or spasticity that may arise from nervous system issues. Its common side effects include dizziness and drowsiness, so caution is advised when performing activities requiring alertness. It is available in oral tablet form.
The Metaxalone market is influenced by the rising prevalence of musculoskeletal disorders like arthritis, chronic back pain, and muscle strains. The growth in ageing populations and sedentary lifestyles across the globe contributes to its demand as a non-opioid alternative for pain management. Its market is further supported by pharmaceutical advancements, including improved formulations like extended-release tablets, which improve patient compliance. The industrial Metaxalone procurement is affected by regulatory requirements like prescription-only status, access to raw materials and active pharmaceutical ingredients, and competition from alternative pain relief treatments. The sourcing is further influenced by patent status, generic competition, and formulation innovations.
Raw Material for Metaxalone Production
According to the Metaxalone production plant project report, the key raw materials used in the production of Metaxalone include (3,5-dimethylphenol)-Triglycidyl Isocyanurate-Methyl Isobutyl Ketone.
Production Process of Metaxalone
The extensive Metaxalone production cost report consists of the following major industrial production process:
- From 3,5-Dimethylphenol and Triglycidyl Isocyanurate: The production process of Metaxalone starts with a reaction of 3,5-dimethylphenol and triglycidyl isocyanurate. The reaction takes place in the presence of methyl isobutyl ketone and potassium hydroxide at room temperature. This mixture was gradually heated and stirred at this temperature for several hours, which led to the formation of the intermediate metaxalone precursor. The reaction mass was then cooled, and the product precipitated. The solid was separated by centrifugation and dried to obtain crude Metaxalone as an off-white solid. The crude Metaxalone was dissolved in chloroform and filtered to produce purified Metaxalone.
Metaxalone is a white to almost white, odourless crystalline powder. It has a molecular formula of C12H15NO3 and a molecular weight of 221.25 g/mol. It has a melting point ranging between 122 and 126 degree Celsius and a boiling point around 225 degree Celsius. It is freely soluble in chloroform, soluble in methanol and 96% ethanol, but almost insoluble in water and ether. It has a logP (octanol-water partition coefficient) value around 2.3, making it moderately lipophilic. The molecule has one hydrogen bond donor, two hydrogen bond acceptors, and three rotatable bonds, with a topological polar surface area of approximately 47.56 Ų. These physical and chemical properties contribute to its moderate bioavailability and central nervous system activity.